Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02736266
Title Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milano Mi 20133 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field